Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Sophonix
company
About
Sophonix is a biotechnology company.
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥100M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2017
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Sophonix focuses on the development, production and sales of in vitro diagnostic instruments and reagents, providing accurate POCT solutions.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥100M
Sophonix has raised a total of
¥100M
in funding over 2 rounds. Their latest funding was raised on
Jun 23, 2020 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 23, 2020 | Series B | ¥100M | 3 |
Zero2IPO Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
Sophonix is funded by 3 investors.
Zero2IPO Capital
and ETP Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Zero2IPO Capital
|
Yes | Series B |
|
|
— | Series B |
Anlongmed Fund
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
